Aging, immunity and cancer

Handbook on Immunosenescence: Basic Understanding and Clinical Applications

Volumn 9781402090639, Issue , 2009, Pages 1119-1138

  Sportès, Claude ^a   Hakim, Frances T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adoptive immunotherapy; Immuno editing; Immuno surveillance; Inflammation; Primary immuno deficiency

Indexed keywords

EID: 84892781557     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-9063-9_55     Document Type: Chapter

References (70)

1. Abe M, Kondo S, Hirano S, Ambo Y, Tanaka E, Morikawa T, Okushiba S and Katoh H (2003) Long-term survival after radical resection of advanced pancreatic cancer: a case report with special reference to CD8+ T-cell infiltration. Int J Gastrointest Cancer 33:107-110
2. Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K, Abrams J, Sznol M, Parkinson D, Hawkins M, Paradise C, Kunkel L and Rosenberg SA (1999) High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 17:2105-2116
3. Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S and Gress R (2004) Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer. J Clin Oncol 22:3886-3892
4. Bonafe M, Barbi C, Storci G, Salvioli S, Capri M, Olivieri F, Valensin S, Monti D, Gonos ES, De BG and Franceschi C (2002) What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians. Exp Gerontol 37:1263-1271
5. Bronte V, Cingarlini S, Marigo I, De Santo C, Gallina G, Dolcetti L, Ugel S, Peranzoni E, Mandruzzato S and Zanovello P (2006) Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. Immunol Invest 35:327-357
6. Bruunsgaard H (2006) The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality. Dan Med Bull 53:285-309
7. Buell JF, Gross TG and Woodle ES (2005) Malignancy after transplantation. Transplantation 80:S254-S264
8. Cameron AJ, Lomboy CT, Pera M and Carpenter HA (1995) Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 109:1541-1546
9. Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, Ohuchi A, Ohuchi K, Shiiba K, Kurokawa Y and Satomi S (2004) Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer 91:1711-1717
10. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS and Barrett AJ (2000) Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 343:750-758
11. Cho Y, Miyamoto M, Kato K, Fukunaga A, Shichinohe T, Kawarada Y, Hida Y, Oshikiri T, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Murakami S, Shinohara T, Itoh T, Okushiba S, Kondo S and Katoh H (2003) CD4 +and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res 63:1555-1559
12. Cui Z and Willingham MC (2004) The effect of aging on cellular immunity against cancer in SR/CR mice. Cancer Immunol Immunother 53:473-478
13. Cui Z, Willingham MC, Hicks AM, Alexander-Miller MA, Howard TD, Hawkins GA, Miller MS, Weir HM, Du W and DeLong CJ (2003) Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci U S A 100:6682-6687
14. D'Arminio Monforte A, Abrams D, Pradier C, Weber R, Bonnet F, De Wit S, Friis-Moller N, Phillips A, Sabin C and Lundgren J (2007) HIV-induced Immunodeficiency and Risk of Fatal AIDS-defining and Non-AIDS-defining Malignancies: Results from the D: A: D Study. 14th Conference on retroviruses and opportunistic infections
15. de Visser KE and Coussens LM (2006) The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 13:118-137
16. de Visser KE, Korets LV and Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411-423
17. Donato F, Boffetta P and Puoti M (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75:347-354
18. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A and Rosenberg SA (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23:2346-2357
19. Dunn GP, Koebel CM and Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6:836-848
20. Dunn GP, Old LJ and Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329-360
21. Eaden JA, Abrams KR and Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526-535
22. Engel AM, Svane IM, Rygaard J and Werdelin O (1997) MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice. Scand J Immunol 45:463-470
23. Enzler T, Gillessen S, Manis JP, Ferguson D, Fleming J, Alt FW, Mihm M and Dranoff G (2003) Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J Exp Med 197:1213-1219
24. Ernst PB and Gold BD (2000) The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 54:615-640
25. Gattinoni L, Powell DJ Jr., Rosenberg SA and Restifo NP (2006) Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6:383-393
26. Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M and Weinberg A (1997) Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158:977-983
27. Hiraoka K, Miyamoto M, Cho Y, Suzuoki M, Oshikiri T, Nakakubo Y, Itoh T, Ohbuchi T, Kondo S and Katoh H (2006) Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 94:275-280
28. Imai K, Matsuyama S, Miyake S, Suga K and Nakachi K (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356:1795-1799
29. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ and Schreiber RD (1998) Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 95:7556-7561
30. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431-436
31. Karin M and Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759
32. Lin EY and Pollard JW (2004a) Macrophages: modulators of breast cancer progression. Novartis Found Symp 256:158-168
33. Lin EY and Pollard JW (2004b) Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90:2053-2058
34. Lin WW and Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175-1183
35. Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH and O'Reilly RJ (1995b) Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response? Bone Marrow Transplant 15:591-594
36. Manning CB, Vallyathan V and Mossman BT (2002) Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2:191-200
37. Miller RA and Chrisp C (2002) T cell subset patterns that predict resistance to spontaneous lymphoma, mammary adenocarcinoma, and fibrosarcoma in mice. J Immunol 169:1619-1625
38. Miyaishi O, Ando F, Matsuzawa K, Kanawa R and Isobe K (2000) Cancer incidence in old age. Mech Ageing Dev 117:47-55
39. Nakakubo Y, Miyamoto M, Cho Y, Hida Y, Oshikiri T, Suzuoki M, Hiraoka K, Itoh T, Kondo S and Katoh H (2003). Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer 89:1736-1742
40. Ochs HD, Smith C I E and Puck JM (2006) In: Ochs HD, Smith CIE and Puck JM (eds) Primary immunodeficiency diseases: a molecular and genetic approach. Oxford University Press
41. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH and Galon J (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353:2654-2666
42. Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, Boni A, Muranski P, Sanchez-Perez L, Palmer DC, Yu Z, Antony PA, Gattinoni L, Rosenberg SA and Restifo NP (2007) Toll-like receptors in tumor immunotherapy. Clin Cancer Res 13:5280-5289
43. Penn I (1995) Sarcomas in organ allograft recipients. Transplantation 60:1485-1491
44. Penn I (1996) Malignant melanoma in organ allograft recipients. Transplantation 61:274-278
45. Peto R, Roe FJ, Lee PN, Levy L and Clack J (1975) Cancer and ageing in mice and men. Br J Cancer 32:411-426
46. Pham SM, Kormos RL, Landreneau RJ, Kawai A, Gonzalez-Cancel I, Hardesty RL, Hattler BG and Griffith BP (1995) Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 60:1623-1626
47. Phan GQ, Attia P, Steinberg SM, White DE and Rosenberg SA (2001) Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma. J Clin Oncol 19:3477-3482
48. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71-78
49. Porter DL Roth MS, Mcgarigle C, Ferrara J L M and Antin JH (1994) Induction of Graft-Versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia. N Engl J Med 330:100-106
50. Provinciali M, Smorlesi A, Donnini A, Bartozzi B and Amici A (2003) Low effectiveness of DNA vaccination against HER-2/neu in ageing. Vaccine 21:843-848
51. Reed MJ, Karres N, Eyman D, Cruz A, Brekken RA and Plymate S (2007). The effects of aging on tumor growth and angiogenesis are tumor-cell dependent. Int J Cancer 120:753-760
52. Rosenberg SA (2000). Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer. Cancer J Sci Am 6 Suppl 1:S2-S7
53. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ and Schreiber RD (2001) IFN-gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107-1111
54. Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI and Trapani JA (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192:755-760
55. Stanta G, Campagner L, Cavallieri F and Giarelli L (1997) Cancer of the oldest old. What we have learned from autopsy studies. Clin Geriatr Med 13:55-68
56. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK and Levin B (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946-1952
57. Street SE, Trapani JA, MacGregor D and Smyth MJ (2002) Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med 196:129-134
58. Stutman O (1974) Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 183:534-536
59. Sullivan KE, Mullen CA, Blaese RM and Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876-885
60. Swann JB and Smyth MJ (2007) Immune surveillance of tumors. J Clin Invest 117:1137-1146
61. Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y and Sugimachi K (2001) Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol 96:574-578
62. Tracey KJ (2002) The inflammatory reflex. Nature 420:853-859
63. Ueno NT, Cheng YC, Rondon G, Tannir NM, Gajewski JL, Couriel DR, Hosing C, de Lima MJ, Anderlini P, Khouri IF, Booser DJ, Hortobagyi GN, Pagliaro LC, Jonasch E, Giralt SA and Champlin RE (2003) Rapid induction of complete donor chimerism by the use of a reducedintensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. Blood 102:3829-3836
64. Varan A, Buyukpamukcu M, Ersoy F, Sanal O, Akyuz C, Kutluk T and Yalcin B (2004) Malignant solid tumors associated with congenital immunodeficiency disorders. Pediatr Hematol Oncol 21:441-451
65. Wakabayashi O, Yamazaki K, Oizumi S, Hommura F, Kinoshita I, Ogura S, aka-Akita H and Nishimura M (2003) CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci 94:1003-1009
66. Whitcomb DC (2004) Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 287:G315-G319
67. Wilson RE, Hager EB, Hampers CL, Corson JM, Merrill JP and Murray JE (1968) Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med 278:479-483
68. Young MR, Kolesiak K, Achille NJ, Meisinger J, Gonzalez E, Liu SW, Wrone-Smith T and Lathers DM (2001) Impact of aging on immune modulation by tumor. Cancer Immunol Immunother 50:315-320
69. Zhang HG and Grizzle WE (2003) Aging, immunity, and tumor susceptibility. Immunol Allergy Clin North Am 23:83-102, vi
70. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC and Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203-213